Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2021. "We delivered strong...

Related Keywords

Canada ,Dublin ,Ireland ,Canadian ,Blaise Coleman ,Company Net ,Branded Pharmaceuticals ,Company Net Debt Leverage Ratio ,Linkedin ,Generic Pharmaceuticals ,Endo Investor Relations Department ,Nasdaq ,Exchange Commission ,International Pharmaceuticals ,Pfizer Inc ,Endo International ,Strides Pharma Science ,Company Loss ,Chief Executive Officer ,Months Ended September ,Diluted Net ,Continuing Operations ,Diluted Weighted Average Shares ,Diluted Net Income ,Adjusted Diluted Weighted Average Shares ,Adjusted Income ,Sterile Injectables ,Note Regarding Forward Looking Statements ,Operating Expenses ,Total Revenues ,Chestnut Ridge ,Strides Pharma Science Limited ,Nasal Spray ,Condensed Consolidated Statement ,Condensed Consolidated Balance Sheet ,Cash Flow ,Qualified Settlement ,Current Report ,Supplemental Financial Information ,Condensed Consolidated Statements ,Net Debt Leverage Ratio ,Net Debt ,Restricted Cash ,Net Debt Leverage ,Debt Leverage Ratio ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Endo International Plc ,